Advertisement
Salesforce
Salesforce

The Scientist

» Big Pharma

Most Recent

image: Gold Dust Missing from Pfizer Lab

Gold Dust Missing from Pfizer Lab

By | December 10, 2012

$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.

1 Comment

image: Opinion: Eliminating Meningitis

Opinion: Eliminating Meningitis

By | September 17, 2012

Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.

1 Comment

image: Pharma's Fake Innovation Crisis?

Pharma's Fake Innovation Crisis?

By | August 13, 2012

Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.

2 Comments

image: Off-Label Drug Disclosure Inadequate

Off-Label Drug Disclosure Inadequate

By | August 7, 2012

Some 85 percent of researchers involved in promoting off-label drug use do not adequately disclose financial conflicts of interest in published articles.

1 Comment

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Overhauling Industry-Sponsored Studies

Overhauling Industry-Sponsored Studies

By | May 23, 2012

Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.

1 Comment

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

image: $785 Million for Tropical Diseases

$785 Million for Tropical Diseases

By | January 31, 2012

A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.

5 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
CEM
CEM
Advertisement
The Scientist
The Scientist
Life Technologies